Tenon Medical shares rise 18.71% intraday as company provides 2025 Q4 revenue guidance up 90% YoY to $1.45M-$1.48M and full-year guidance up 20% to $3.91M-$3.94M.

Tenon Medical surged 18.71% intraday as the company released preliminary 2025 Q4 revenue estimates of $1.45–$1.48 million (up ~90% YoY) and full-year revenue guidance of $3.91–$3.94 million (up ~20% YoY), indicating accelerated performance.